We are live on ! Find out more
MS

Marshall & Sullivan Portfolio holdings

AUM $216M
1-Year Est. Return 12.97%
This Fund
S&P 500
This Quarter Est. Return
+9.42%
1 Year Est. Return
+12.97%
3 Year Est. Return
+82%
5 Year Est. Return
+98.09%
10 Year Est. Return
+292.06%
AUM
$159M
AUM Growth
+$14.8M
Cap. Flow
+$3.09M
Cap. Flow %
1.94%
Top 10 Hldgs %
47.95%
Holding
96
New
59
Increased
9
Reduced
23
Closed

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.47M
2
GBCI icon
Glacier Bancorp
GBCI
+$1.43M
3
NKE icon
Nike
NKE
+$1.16M
4
MSFT icon
Microsoft
MSFT
+$504K
5
AMZN icon
Amazon
AMZN
+$317K

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$1.39M
2
UNH icon
UnitedHealth
UNH
+$624K
3
PEP icon
PepsiCo
PEP
+$304K
4
LIN icon
Linde
LIN
+$303K
5
SCHW
Charles Schwab
SCHW
+$290K

Sector Composition

Rank Sector Weight
1 Healthcare 23.49%
2 Technology 17.51%
3 Consumer Discretionary 12.33%
4 Financials 9.62%
5 Consumer Staples 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWM icon
1
iShares Russell 2000 ETF
IWM
$79.1B
$18.3M 11.51%
105,211
-1,581
-1% -$281K
MSFT icon
2
Microsoft
MSFT
$2.9T
$8.62M 5.41%
35,957
+2,102
+6% +$504K
UNH icon
3
UnitedHealth
UNH
$382B
$7.17M 4.49%
13,517
-1,178
-8% -$624K
LIN icon
4
Linde
LIN
$236B
$6.57M 4.12%
20,154
-966
-5% -$303K
SCHW
5
Charles Schwab
SCHW
$182B
$6.36M 3.99%
76,442
-3,736
-5% -$290K
DHR icon
6
Danaher
DHR
$138B
$6.31M 3.95%
26,796
-1,133
-4% -$263K
VWO icon
7
Vanguard FTSE Emerging Markets ETF
VWO
$117B
$6M 3.77%
154,001
-6,383
-4% -$243K
HD icon
8
Home Depot
HD
$337B
$5.96M 3.74%
18,869
-645
-3% -$196K
MA icon
9
Mastercard
MA
$498B
$5.56M 3.49%
15,993
-308
-2% -$101K
PEP icon
10
PepsiCo
PEP
$196B
$5.55M 3.48%
30,715
-1,705
-5% -$304K
SYK icon
11
Stryker
SYK
$135B
$5.55M 3.48%
22,690
-518
-2% -$118K
JNJ icon
12
Johnson & Johnson
JNJ
$640B
$5.22M 3.27%
29,540
-856
-3% -$148K
TMO icon
13
Thermo Fisher Scientific
TMO
$214B
$5.19M 3.25%
9,420
-388
-4% -$206K
MNST icon
14
Monster Beverage
MNST
$95.1B
$4.8M 3.01%
94,492
-2,686
-3% -$130K
BDX icon
15
Becton Dickinson
BDX
$46.4B
$4.74M 2.97%
18,649
-367
-2% -$86.6K
CCK icon
16
Crown Holdings
CCK
$13B
$4.73M 2.96%
57,492
-400
-0.7% -$31.9K
GOOGL icon
17
Alphabet (Google) Class A
GOOGL
$4.12T
$4.7M 2.95%
53,268
+7
+0% +$665
FISV
18
Fiserv Inc
FISV
$29.7B
$4.67M 2.93%
46,196
-397
-0.9% -$39.5K
ADBE icon
19
Adobe
ADBE
$105B
$4.11M 2.58%
12,217
-14
-0.1% -$4.48K
RTX icon
20
RTX Corp
RTX
$290B
$3.82M 2.4%
37,894
-220
-0.6% -$20.7K
FTV icon
21
Fortive
FTV
$18.2B
$3.81M 2.39%
78,677
+373
+0.5% +$18.1K
AAPL icon
22
Apple
AAPL
$4.97T
$3.51M 2.2%
26,982
+10,271
+61% +$1.47M
BKNG icon
23
Booking.com
BKNG
$156B
$3.35M 2.1%
41,550
-75
-0.2% -$5.69K
EEM icon
24
iShares MSCI Emerging Markets ETF
EEM
$27.5B
$3.11M 1.95%
82,044
+2,894
+4% +$107K
LRCX icon
25
Lam Research
LRCX
$316B
$3.07M 1.92%
72,980
-440
-0.6% -$18.4K

Similar funds

Marshall & Sullivan's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall & Sullivan held 96 positions worth $159M, up 10% from $145M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Marshall & Sullivan's Q4 2022 filing shows 59 new, 9 increased and 23 reduced positions. Its largest new stake was Glacier Bancorp: 26,542 shares worth $1.31M. The largest sale was Meta Platforms (Facebook), an estimated $1.39M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall & Sullivan's largest Q4 2022 buy was Glacier Bancorp: 26,542 shares worth $1.31M.
  • Marshall & Sullivan added most to Apple in Q4 2022, an estimated $1.47M increase.
  • Marshall & Sullivan's biggest Q4 2022 reduction was Meta Platforms (Facebook), cutting an estimated $1.39M.
  • Marshall & Sullivan's ten largest holdings make up 48% of its $159M portfolio in Q4 2022.
  • Marshall & Sullivan opened 59 new positions and closed 0 in Q4 2022.
  • Marshall & Sullivan's portfolio value rose 10% quarter-over-quarter to $159M.

Based on Marshall & Sullivan's 13F filing for Q4 2022, filed 18 Jan 2023.